News - Pharm-Sintez

Filter

Current filters:

Pharm-Sintez

Popular Filters

Pfizer to transfer Factor VIII license to Russia's Biocad; Pharm-sintez cancer plans

26-06-2012

US drug behemoth Pfizer (NYSE: PFE) is finalizing confidions for the transfer of a license for the production…

BiocadEuropeFactor VIIILicensingMarkets & MarketingOncologyPfizerPharm-SintezPharmaceutical

Company Spotlight

Fibrotech

Fibrotech

Back to top